Biohaven (NYSE:BHVN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	3.00 / 1.05M
Day Range	- - -
52 Wk Range	26.80 - 62.21
Market Cap	$3.96B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	36
Short Interest	8.71%
Days to Cover	8.78

Recent News

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval

Biohaven's BHV-1300 shows >60% IgG reduction in early trials with promising safety data, advancing its MoDE platform and regulatory milestones.

Vandana Singh

Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?

8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well.

Lekha Gupta

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study

Biohaven reported taldefgrobep data showing motor function gains in SMA and plans to advance obesity studies with an autoinjector in 4Q24.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	3.00 / 1.05M
Day Range	- - -
52 Wk Range	26.80 - 62.21
Market Cap	$3.96B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	36
Short Interest	8.71%
Days to Cover	8.78

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biohaven (BHVN) stock?

You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.

View our list of the best stock brokerages

Who are Biohaven (BHVN) competitors?

Other companies in Biohaven’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for Biohaven (BHVN) stock?

Biohaven has a consensus price target of $78.17.

What is the current price for Biohaven (BHVN)?

The stock price for Biohaven (NYSE: BHVN) is $39.12 last updated December 17, 2024 at 4:00 PM EST.

Does Biohaven (BHVN) pay a dividend?

There are no upcoming dividends for Biohaven.

When is Biohaven (NYSE:BHVN) reporting earnings?

Biohaven’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is Biohaven (BHVN) going to split?

There is no upcoming split for Biohaven.

What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Comments

Biohaven

Biohaven (BHVN) Forecast